We demonstrated that treatment with CNP-miR146a following MRSA infection significantly reduced expression and production of IL-6, IL-8, IL-1β, and TNFα, which may function to prevent amplification of the positive feedback inflammatory cascade that is hallmark of ARDS. The gene discussed is IL1B; the disease is acute respiratory distress syndrome.